Researchers

NAKAGAWA Kazuhiko

NAKAGAWA Kazuhiko
Specially Appointed Professor
Faculty Kindai University Hospital
Researchmap https://researchmap.jp/Nakagawa_Kazuhiko

Education and Career

Education

  • - 1983 , Kumamoto University, Faculty of Medicine,
  • - 1983 , Kumamoto University, School of Medicine,

Research Activities

Research Areas

  • Life sciences , Respiratory medicine

Research Interests

臨床腫瘍学, Medical Oncology

Published Papers

  1. Final overall survival analysis of the APPLE study: atezolizumab and platinum-pemetrexed with or without bevacizumab for metastatic nonsquamous non-small cell lung cancer.
    Yoshimasa Shiraishi; Junji Kishimoto; Shunichi Sugawara; Hideaki Mizutani; Haruko Daga; Koichi Azuma; Hirotaka Matsumoto; Osamu Hataji; Kazumi Nishino; Masahide Mori; Takehito Shukuya; Haruhiro Saito; Motoko Tachihara; Kaoru Tanaka; Asuka Tsuya; Kazushige Wakuda; Noriko Yanagitani; Tomohiro Sakamoto; Junko Baba; Akito Hata; Morihito Okada; Toshiyuki Kozuki; Yuki Sato; Yuriko Takahata; Tadaaki Yamada; Nobuyuki Yamamoto; Kazuhiko Nakagawa; Isamu Okamoto
    Lung cancer (Amsterdam, Netherlands)  217  , 109447-109447, Jul. 2026 
  2. Segmentectomy versus lobectomy in non-small-cell lung cancer with pathologically invasive features: a post-hoc supplementary analysis of a multicenter, Phase 3 trial JCOG0802/WJOG4607L.
    Shinya Katsumata; Atsushi Kamigaichi; Takaki Akamine; Mitsuhiro Isaka; Masashi Wakabayashi; Noriko Mitome; Masaya Yotsukura; Takahiro Mimae; Aritoshi Hattori; Tomohiro Miyoshi; Makoto Endo; Kazuo Nakagawa; Hiroshige Yoshioka; Yasuhiro Tsutani; Tetsuya Isaka; Tomohiro Maniwa; Yoshihisa Shimada; Ryu Nakajima; Kenji Suzuki; Keiju Aokage; Hisashi Saji; Masahiro Tsuboi; Morihito Okada; Hisao Asamura; Yuta Sekino; Kenichi Nakamura; Haruhiko Fukuda; Shun-Ichi Watanabe
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer  , 103916-103916, 11, May. 2026 
  3. Mutation-Specific Response to Ramucirumab in EGFR-Mutated Metastatic NSCLC: Insights From Circulating Cell-Free DNA Profiling (Liquid Biopsy Japan Addendum of RELAY Phase 3 Randomized Study).
    Kazuto Nishio; Kazuko Sakai; Makoto Nishio; Takashi Seto; Carla Visseren-Grul; Michelle Carlsen; Sotaro Enatsu; Tomoko Matsui; Kazuhiko Nakagawa
    JTO clinical and research reports  7  (5)  , 100963-100963, May. 2026 

MORE

Books etc

  1. 入門腫瘍内科学 , 西條 長宏; 中川 和彦; 西尾 和人; 荒尾 徳三; 石岡 千加史; 田村 和夫; 南 博信; 古瀬 純司; 赤座 英之; 中西 洋一; 木浦 勝行 , 篠原出版新社 , 2009

Conference Activities & Talks

  1. WJOGの現状と今後の展望 , 中川和彦; 武田晃司; 室 圭; 高野利実; 山本信之 , 第94回日本胃癌学会総会 , 4, Mar. 2022
  2. Distinctive characteristics MSI-H in chemo;immune therapy for gastric cancer , Hisato Kawakami; Kei Muro; Kazuhiko Nakagawa , 第94回日本胃癌学会総会 , 3, Mar. 2022
  3. FOLRα positive gastric cancer exhibits chemorisistance that is overcome by a novel ADC,MoRAb-202 , Hisato Kawakami; Hitomi Sakai; Tekashi Teramura; Yuuta Onodera; Erizabeth Somers; Keiji Furuuchi; Yoshimitsu Uenaka; Ryoji Kato; Kazuhiko Nakagawa , 第94回日本胃癌学会総会 , 3, Mar. 2022

MORE

MISC

  1. PTPRRのダウンレギュレーションにより誘導されるEGFRの恒常的活性化はKRAS阻害薬耐性を付与する(Constitutive activation of EGFR induced by downregulation of PTPRR confers resistance to KRAS inhibitors) , 金村 宙昌; 竹原 俊幸; 前西 修; 冨田 秀太; 岩脇 菜摘; 國政 啓; 中山 智裕; 渡邊 諭美; 鈴木 慎一郎; 坂井 和子; 東 公一; 西尾 和人; 中川 和彦; 林 秀敏; 米阪 仁雄 , 肺癌 , 65 , 5 , 394 , 394 , Nov. 2025
  2. A prospective biomarker study of durvalumab after dCCRT in patients with unresectable stage III NSCLC (WJOG11518L) , 豆鞘伸昭; 原谷浩司; 山口哲平; 関根朗雅; 三浦理; 岩永健太郎; 山口正史; 西川和男; 水柿秀紀; 工藤慶太; 中村靖司; 坂井和子; 冨田秀太; 千葉康敬; 伊藤彰彦; 西尾和人; 山本信之; 中川和彦; 林秀敏 , 日本臨床腫瘍学会学術集会(CD-ROM) , 21st , 2024
  3. Overcoming resistance to KRAS inhibitors due to EGFR activation via PTPRR , 金村宙昌; 鈴木慎一郎; 坂井和子; 西尾和人; 中川和彦; 米阪仁雄 , 日本がん分子標的治療学会学術集会プログラム・抄録集 , 28th , 2024

MORE

Patents

  1. 非小細胞肺癌に対する化学療法の治療効果予測方法 , 中川 和彦, 萩本啓文

Awards & Honors

  1. 1997, 米国臨床腫瘍学会トラベルアワード(ASCO)
  2. 1996, 米国癌学会トラベルアワード(AACR)
  3. 1988, 米国臨床腫瘍学会トラベルアワード(ASCO)

Research Grants & Projects

  1. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, A biomarker study of heregulin to predict efficacy of anti-HER2 drugs in HER2-positive breast and gastric cancer , Kindai University
  2. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Antitumor Action of the MET Tyrosine Kinase Inhibitor in Gastric Cancer Positive for MET Amplification
  3. Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research, Multiplex molecular profiling in advanced non-small cell lung cancers

MORE